Glia-A is a solid phase enzyme immunoassay employing highly purified alpha-Gliadin for the quantitative detection of IgA antibodies against gliadin in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy).
Glia-G is a solid phase enzyme immunoassay employing highly purified alpha-Gliadin for the quantitative detection of IgG antibodies against Gliadin in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy).
The tTg-A New generation is a solid phase enzyme immunoassay for the quantitative detection of IgA antibodies against neo-epitopes of tissue transglutaminase (tTG) in human serum. The assay employing human recombinant transglutaminase crosslinked with gliadin-specific peptides displays neo-epitopes of tTg which ensures a significantly increased sensitivity and specificity of the test. The assay is a tool for the diagnosis and monitoring of celiac disease (gluten-sensitive enteropathy).
The tTg-G New Generation is a solid phase enzyme immunoassay for the quantitative detection of IgG antibodies against neo-epitopes of tissue transglutaminase (tTG) in human serum. The assay employing human recombinant transglutaminase crosslinked with gliadin-specific peptides displays neo-epitopes of tTg which ensures a significantly increased sensitivity and specificity of the test. The assay is a tool for the diagnosis and monitoring of celiac disease (gluten-sensitive enteropathy).
ASCA-A is a solid phase enzyme immunoassay (ELISA) employing highly purified mannan for the quantitative detection of IgA anti-Saccharomyces cerevisiae antibodies (ASCA) in human serum. ASCA recognize specifically mannan, a component of the outer cell wall of yeast. The assay is highly specific and sensitive for Crohn`s disease.
ASCA-G is a solid phase enzyme immunoassay (ELISA) employing highly purified mannan for the quantitative detection of IgG anti-Saccharomyces cerevisiae antibodies (ASCA) in human serum. ASCA recognize specific mannan, a component of the outer cell wall of yeast. The assay is highly specific and sensitive for Crohn`s disease.
Crohn`s-Check is a solid phase enzyme immunoassay (ELISA) employing highly purified mannan for the combined quantitative detection of anti-Saccharomyces cerevisiae IgA and IgG antibodies (ASCA) in human serum. ASCA recognize specific mannan, a component of the outer cell wall of yeast. The assay is highly specific and sensitive for Crohn`s disease.
CeliCheck New Generation is a solid phase enzyme immunoassay for the combined quantitative detection of IgA and IgG antibodies against neo-epitopes of tissue transglutaminase (tTG) in human serum. The assay employing human recombinant tTG crosslinked with gliadin-specific peptides displays neo-epitopes of tTg which ensures a significantly increased sensitivity and specificity of the test. The assay is a tool for the diagnosis and monitoring of celiac disease (gluten-sensitive enteropathy).
Parietal cell is a solid phase enzyme immunoassay employing purified native H+ /K+ – ATPase for the quantitative detection of antibodies against parietal cells in human serum. Antibodies against parietal cells can be found in pernicious anemia.
Intrinsic factor is a solid phase enzyme immunoassay with recombinant human intrinsic factor for the quantitative detection of IgG antibodies against intrinsic factor. The assay is a tool in the diagnosis of pernicious anaemia (Biermer`s anaemia)
DGP-A is a solid phase enzyme immunoassay employing synthetic, deamidated gliadin-derived peptides for the quantitative detection of IgA antibodies against deamidated Gliadin-specific peptides (DGP) in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy).
DGP-G is a solid phase enzyme immunoassay employing synthetic, deamidated gliadin-derived peptides for the quantitative detection of IgG antibodies against deamidated Gliadin-specific peptides (DGP) in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy).
DGP-Check is a solid phase enzyme immunoassay employing synthetic, deamidated gliadin-derived peptides for the combined quantitative detection of IgA and IgG antibodies against deamidated Gliadin-specific peptides (DGP) in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy).
Calprest® NG quantitative detection of human calprotectin in faecal extracts
ELISA 96 T
Calprest®NG is a quantitative ELISA assay for detecting concentration of fecal calprotectin. Calprest®NGcan be used as an in vitro diagnostic to aid in the diagnosis of Inflammatory Bowel Diseases (IBD, Crohn’s disease and ulcerative colitis) and to differentiate IBD from Irritable Bowel Syndrome (IBS) in conjunction with other clinical and laboratory findings.